Radiofrequency Ablation Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Radiofrequency Ablation Devices Market by Product Type (RF Generators, Reusable Products, Disposable Products), By Application (Pain management, Gynecology, Hypertension, Cosmetology, Surgical Oncology, Cardiology & Cardiac Rhythm Management), By End User (Hospitals, Ambulatory Surgical Centers, Others) and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Radiofrequency Ablation Devices Market size is valued at USD 3.5 billion in 2021 and is expected to reach USD 6.99 billion by 2028, at a CAGR of 10.3% during the forecast period 2022-2028. This report studies global radiofrequency ablation devices market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Radiofrequency ablation (RFA) is a procedure used to reduce pain and is also used to treat medical conditions such as cancer tumors with help of imaging techniques. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area. RFA can be used to help patients with chronic (long-lasting) low-back and neck pain and pain related to the degeneration of joints from arthritis. In July 2017, Stryker has announced that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. Medtronic introduced the OsteoCool RF Ablation device in Canada in April 2017 for the detection of bone metastases. This is the only dual-probe RF ablation device available, allowing for customized, adaptable, and predictable therapy.

Radiofrequency Ablation Devices Market

MARKET SUMMARY
-
10.3% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10.3%
  • Largest Market– North America
  • Fastest Growing- Europe

Radiofrequency Ablation Devices Market

  • Radiofrequency Ablation Devices Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, distribution channel and region.
Market Leaders
  • Smith & Nephew plc (U.K.)
  • Olympus Corporation (Japan)
  • Jude Medical, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • CONMED Corporation (U.S.
Radiofrequency Ablation Devices Market

Drivers and Restraints

Increase in the prevalence of chronic diseases such as cancer is the key factor attributing the growth of the radiofrequency ablation devices market. Rising geriatric population along with health issues is anticipating the growth of the market. Increase in the adoption minimal invasive procedures by the patient population is enhancing the growth of the market. The increase in the technological advancements are providing an opportunity for the growth of the growth of the market However, the high cost of the treatment is hindering the growth of the market. The availability of alternate procedures is hampering the growth of the radiofrequency ablation devices market.


Radiofrequency Ablation Devices Market Regional Analysis

North America dominates the market

North America radiofrequency ablation devices market is the dominant market in the global radiofrequency ablation devices market. Owing to the technological advancements this region is projecting higher growth in the market. The increase in the geriatric population in this region is anticipating the growth of the radiofrequency ablation devices market. The rising incidence of cancer is enriching the growth of the market in this region. According to the United States Cancer Statistics: 1999–2014 incidence and Mortality Web-based Report, 591,686 people died of cancer in the United States in 2014. Europe and the Asia Pacific radiofrequency ablation devices market falls next to the North America radiofrequency ablation devices market. Asia Pacific radiofrequency ablation devices market is projected to grow over the forecasted period owing to the presence of the emerging economies and the presence of huge patient population.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
Radiofrequency Ablation Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

 

  • Smith & Nephew plc (U.K.)
  • Olympus Corporation (Japan)
  • Jude Medical, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • CONMED Corporation (U.S.)
  • AngioDynamics, Inc. (U.S.)
  • AtriCure, Inc. (U.S.)
  • Medtronic, Inc. (U.S.)
  • Biosense Webster, Inc. (U.S.)

Description

Radiofrequency Ablation Devices Market size is valued at USD 3.5 billion in 2021 and is expected to reach USD 6.99 billion by 2028, at a CAGR of 10.3% during the forecast period 2022-2028. This report studies global radiofrequency ablation devices market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Radiofrequency ablation (RFA) is a procedure used to reduce pain and is also used to treat medical conditions such as cancer tumors with help of imaging techniques. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area. RFA can be used to help patients with chronic (long-lasting) low-back and neck pain and pain related to the degeneration of joints from arthritis. In July 2017, Stryker has announced that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. Medtronic introduced the OsteoCool RF Ablation device in Canada in April 2017 for the detection of bone metastases. This is the only dual-probe RF ablation device available, allowing for customized, adaptable, and predictable therapy.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX